MedPath

Selenomethionine

Generic Name
Selenomethionine
Drug Type
Small Molecule
Chemical Formula
C5H11NO2Se
CAS Number
3211-76-5
Unique Ingredient Identifier
964MRK2PEL

Overview

Selenomethionine is a naturally occuring amino acid in some plant materials such as cereal grains, soybeans and enriched yeast but it cannot be synthesized from animals or humans. It can be produced from post-structural modifications. In vivo, selenomethionine plays an essential role in acting as an antioxidant, where it depletes reactive oxygen species (ROS) and aids in the formation and recycling of glutathione, another important antioxidant. In comparison to selenite, which is the inorganic form of selenium, the organic form of selenomethionine is more readily absorbed in the human body. Selenomethionin is used in biochemical laboratories where its incorporation into proteins that need to be visualized enhances the performance of X-ray crystallography.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2022/05/06
Phase 1
Recruiting
2021/07/07
Phase 1
Completed
University of Auckland, New Zealand
2015/08/28
Phase 1
Completed
2010/09/29
Early Phase 1
UNKNOWN

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Marnel Pharmaceuticals, Inc.
0682-3001
ORAL
50 ug in 1 1
5/2/2014
Nephro-Tech, Inc.
59528-1988
ORAL
70 ug in 1 1
7/14/2021
JayMac Pharmaceuticals LLC
64661-811
ORAL
50 ug in 1 1
5/3/2012

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
Men's Multi
326959
Medicine
A
12/2/2019
MaxN-Fuze Multivitamins
288444
Max Health & Living Australia Pty Ltd
Medicine
A
5/1/2017
Kids Multi
329564
Medicine
A
2/6/2020
Orthoplex Clinical C
299281
Medicine
A
2/2/2018
BLACKMORES ULTIMATE RADIANT SKIN
364753
Medicine
A
5/6/2021
NutriVital Selenium Forte 150
316263
Medicine
A
4/8/2019
USANA HealthPak
350153
Medicine
A
11/30/2020
Supervite Multivitamin + Ginseng
312495
Medicine
A
12/13/2018
METAGENICS ENERGYX TROPICAL FLAVOUR
343670
Medicine
A
9/17/2020
Ultra Muscleze Forest Berries
305454
Medicine
A
6/27/2018

Health Canada Drug Approvals

Approved Product
Company
DIN
Dosage Form
Strength
Market Date
No Health Canada approvals found for this drug.

CIMA AEMPS Drug Approvals

Approved Product
Company
Registration Number
Pharmaceutical Form
Prescription Type
Status
No CIMA AEMPS (Spain) approvals found for this drug.

Philippines FDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Philippines FDA approvals found for this drug.

Saudi SFDA Drug Approvals

Approved Product
Company
License Number
Dosage Form
Strength
Approval Date
No Saudi SFDA approvals found for this drug.

Malaysia NPRA Drug Approvals

Approved Product
Company
Registration Number
Dosage Form
Strength
Approval Date
No Malaysia NPRA approvals found for this drug.

UK EMC Drug Information

Medicine Name
MA Holder
MA Number
Pharmaceutical Form
Active Ingredient
Authorization Date
No UK EMC drug information found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.